Stock Research: Bio-Rad Laboratories

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Bio-Rad Laboratories

NYSE:BIO US0905722072
72
  • Value
    95
  • Growth
    15
  • Safety
    Safety
    67
  • Combined
    86
  • Sentiment
    57
  • 360° View
    360° View
    72
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Bio-Rad Laboratories develops, manufactures, and markets products for life science research and clinical diagnostics. It operates in the Life Science and Clinical Diagnostics industries. Its products are sold globally to hospital laboratories, diagnostic reference laboratories, and physician office laboratories. In the last fiscal year, the company had a market cap of $6784 million, profits of $1379 million, and revenue of $2567 million, with 7700 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 72 (better than 72% compared with alternatives), overall professional sentiment and financial characteristics for the stock Bio-Rad Laboratories are above average. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Bio-Rad Laboratories. The consolidated Value Rank has an attractive rank of 67, which means that the share price of Bio-Rad Laboratories is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 67% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 95. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 57. But the consolidated Growth Rank has a low rank of 15, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 85 of its competitors have better growth. ...read more

more
Index
S&P 500
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
67 61 60 49
Growth
15 3 9 17
Safety
Safety
95 97 86 96
Sentiment
57 13 36 61
360° View
360° View
72 25 45 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
50 40 69 88
Opinions Change
94 8 50 50
Pro Holdings
n/a 31 24 65
Market Pulse
46 40 43 16
Sentiment
57 13 36 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
67 61 60 49
Growth
15 3 9 17
Safety Safety
95 97 86 96
Combined
86 64 50 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
34 32 47 10
Price vs. Earnings (P/E)
64 64 57 50
Price vs. Book (P/B)
82 84 85 100
Dividend Yield
1 1 1 1
Value
67 61 60 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
12 12 20 7
Profit Growth
22 26 34 68
Capital Growth
32 11 29 27
Stock Returns
59 51 27 55
Growth
15 3 9 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
58 60 62 82
Refinancing
71 70 63 49
Liquidity
57 64 63 81
Safety Safety
95 97 86 96

Similar Stocks

Discover high‑ranked alternatives to Bio-Rad Laboratories and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.